Clinical Trials Browser

Phase 4 × Prostatic Neoplasms × Lutetium × Clear all

NCT05803941 2025-04-24

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Phase 4 Recruiting

Prostatic Neoplasms